The prior ORCA-V1 trial showed efficacy of cytisinicline for vapers looking to quit. For smokers, the ORCA-2 trial showed ...

Paid for by Consumer Action for a Strong Economy. For decades, U.S. tobacco policy has been stagnant. Bureaucracy and ...

Smokers receiving CBT treatment tolerated a smoking cessation intervention well, without interference in the primary treatment goals.

Disadvantaged households have higher rates of smoking, putting pressure on their household budgets, University of Queensland ...

Last year, only 11 percent of U.S. adults reported smoking cigarettes in the past week, half the number of a decade prior.

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to ...

For decades, smokers have struggled to break free from the grip of nicotine addiction. And while traditional methods like ...

Achieve may not actually achieve its plans or product development goals in a timely manner ... the risk that new developments in the smoking and vaping cessation landscapes require changes ...

Smokers and people who recently quit are more likely to face complications after having an operation than non-smokers, a new ...

EARLY attainment and maintenance of guideline-directed medical therapy (GDMT) goals, particularly blood pressure control, are ...